Recursion Pharmaceuticals Needs A Clinical Breakthrough To Pique Interest
Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
STAT20h
The view from overseas on tumult in U.S. science
Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe ...
Buy Aurobindo Pharma; target of Rs 1445: ICICI Securities
ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1445 in its ...
Buy Aurobindo Pharma; target of Rs 1591: KR Choksey
KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1591 in its ...